Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil versus cyclophosphamide versus leflunomide for maintenance therapy in ANCA-associated systemic vasculitis with renal involvement in remission
ChiCTR-TRC-10000990Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) comparing Cyclophosphamide + glucocorticoids, Leflunomide + glucocorticoids and Mycophenolate mofetil + glucocorticoids (3 arms). Primary endpoint: relapse rate. Started Sep 2010; status: completed.
02
Drugs
cyclophosphamideleflunomidemycophenolate mofetil
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on ChiCTR-TRC-10000990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000990.